Filing Details

Accession Number:
0000711377-12-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-26 17:33:22
Reporting Period:
2012-11-20
Filing Date:
2012-11-26
Accepted Time:
2012-11-26 17:33:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380814 Charles A. Fischer 620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-20 11,250 $9.02 14,250 No 4 M Direct
Common Stock Disposition 2012-11-20 11,250 $42.98 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Acquisiton 2012-11-20 11,250 $0.00 11,250 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,000 2016-11-03 No 4 M Direct
Footnotes
  1. These NQ options were granted on 11/3/2006, vested equally each year over a three year period, and expire on 11/3/2016